首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Characterization of ABT-494, a Second Generation Jak1 Selective Inhibitor.
被引:0
|
作者
:
Graff, Candace
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
Graff, Candace
[
1
]
Schwartz, Annette
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
Schwartz, Annette
[
1
]
Voss, Jeffrey
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Pharmaceut, Worcester, MA USA
AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
Voss, Jeffrey
[
2
]
Wishart, Neil
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Pharmaceut, Worcester, MA USA
AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
Wishart, Neil
[
2
]
Olson, Lisa
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
Olson, Lisa
[
1
]
George, Jonathon
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Pharmaceut, Worcester, MA USA
AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
George, Jonathon
[
2
]
Hyland, Deborah
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Pharmaceut, Worcester, MA USA
AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
Hyland, Deborah
[
2
]
Camp, Heidi
论文数:
0
引用数:
0
h-index:
0
机构:
Abbvie, Winnetka, IL USA
AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
Camp, Heidi
[
3
]
机构
:
[1]
AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
[2]
AbbVie Pharmaceut, Worcester, MA USA
[3]
Abbvie, Winnetka, IL USA
来源
:
ARTHRITIS & RHEUMATOLOGY
|
2014年
/ 66卷
关键词
:
D O I
:
暂无
中图分类号
:
R5 [内科学];
学科分类号
:
1002 ;
100201 ;
摘要
:
1499
引用
收藏
页码:S659 / S660
页数:2
相关论文
共 50 条
[21]
Atomic Simulation of the Binding of JAK1 and JAK2 with the Selective Inhibitor Ruxolitinib
Kondratyev, Maxim
论文数:
0
引用数:
0
h-index:
0
机构:
Russian Acad Sci, Inst Cell Biophys, Pushchino 142290, Russia
Russian Acad Sci, Inst Cell Biophys, Pushchino 142290, Russia
Kondratyev, Maxim
Rudnev, Vladimir R.
论文数:
0
引用数:
0
h-index:
0
机构:
Biobanking Grp, Moscow 109028, Russia
Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142290, Russia
Russian Acad Sci, Inst Cell Biophys, Pushchino 142290, Russia
Rudnev, Vladimir R.
Nikolsky, Kirill S.
论文数:
0
引用数:
0
h-index:
0
机构:
Biobanking Grp, Moscow 109028, Russia
Russian Acad Sci, Inst Cell Biophys, Pushchino 142290, Russia
Nikolsky, Kirill S.
Stepanov, Alexander A.
论文数:
0
引用数:
0
h-index:
0
机构:
Biobanking Grp, Moscow 109028, Russia
Russian Acad Sci, Inst Cell Biophys, Pushchino 142290, Russia
Stepanov, Alexander A.
Petrovsky, Denis, V
论文数:
0
引用数:
0
h-index:
0
机构:
Biobanking Grp, Moscow 109028, Russia
Russian Acad Sci, Inst Cell Biophys, Pushchino 142290, Russia
Petrovsky, Denis, V
Kulikova, Liudmila, I
论文数:
0
引用数:
0
h-index:
0
机构:
Biobanking Grp, Moscow 109028, Russia
Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142290, Russia
Inst Math Problems Biol RAS, Pushchino 142290, Russia
Russian Acad Sci, Inst Cell Biophys, Pushchino 142290, Russia
Kulikova, Liudmila, I
Kopylov, Arthur T.
论文数:
0
引用数:
0
h-index:
0
机构:
Biobanking Grp, Moscow 109028, Russia
Russian Acad Sci, Inst Cell Biophys, Pushchino 142290, Russia
Kopylov, Arthur T.
Malsagova, Kristina A.
论文数:
0
引用数:
0
h-index:
0
机构:
Biobanking Grp, Moscow 109028, Russia
Russian Acad Sci, Inst Cell Biophys, Pushchino 142290, Russia
Malsagova, Kristina A.
Kaysheva, Anna L.
论文数:
0
引用数:
0
h-index:
0
机构:
Biobanking Grp, Moscow 109028, Russia
Russian Acad Sci, Inst Cell Biophys, Pushchino 142290, Russia
Kaysheva, Anna L.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,
2022,
23
(18)
[22]
A PHASE III RANDOMISED PLACEBO-CONTROLLED DOUBLE-BLIND STUDY OF UPADACITINIB (ABT-494), A SELECTIVE JAK-1 INHIBITOR, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
Burmester, Gerd R.
论文数:
0
引用数:
0
h-index:
0
机构:
Charite, Rheumatol & Clin Immunol, Berlin, Germany
Charite, Rheumatol & Clin Immunol, Berlin, Germany
Burmester, Gerd R.
Kremer, Joel
论文数:
0
引用数:
0
h-index:
0
机构:
Albany Med Coll, Rheumatol, Albany, NY 12208 USA
Charite, Rheumatol & Clin Immunol, Berlin, Germany
Kremer, Joel
论文数:
引用数:
h-index:
机构:
van den Bosch, Filip
Li, Yihan
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, Clin Dev, N Chicago, IL USA
Charite, Rheumatol & Clin Immunol, Berlin, Germany
Li, Yihan
Zhou, Yijie
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, Clin Dev, N Chicago, IL USA
Charite, Rheumatol & Clin Immunol, Berlin, Germany
Zhou, Yijie
Othman, Ahmed A.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, Clin Dev, N Chicago, IL USA
Charite, Rheumatol & Clin Immunol, Berlin, Germany
Othman, Ahmed A.
Pangan, Aileen L.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, Clin Dev, N Chicago, IL USA
Charite, Rheumatol & Clin Immunol, Berlin, Germany
Pangan, Aileen L.
Camp, Heidi S.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, Clin Dev, N Chicago, IL USA
Charite, Rheumatol & Clin Immunol, Berlin, Germany
Camp, Heidi S.
RHEUMATOLOGY,
2018,
57
[23]
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study of Upadacitinib (ABT-494), a Selective JAK-1 Inhibitor, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Conventional Synthetic Dmards
Burmester, Gerd R.
论文数:
0
引用数:
0
h-index:
0
机构:
Free Univ, Dept Rheumatol & Clin Immunol, Charite Univ Med Berlin, Berlin, Germany
Humboldt Univ, Berlin, Germany
Free Univ, Dept Rheumatol & Clin Immunol, Charite Univ Med Berlin, Berlin, Germany
Burmester, Gerd R.
Kremer, Joel
论文数:
0
引用数:
0
h-index:
0
机构:
Albany Med Coll, Albany, NY 12208 USA
Free Univ, Dept Rheumatol & Clin Immunol, Charite Univ Med Berlin, Berlin, Germany
Kremer, Joel
论文数:
引用数:
h-index:
机构:
van Den Bosch, Filip
Li, Yihan
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, N Chicago, IL USA
Free Univ, Dept Rheumatol & Clin Immunol, Charite Univ Med Berlin, Berlin, Germany
Li, Yihan
Zhou, Yijie
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, N Chicago, IL USA
Free Univ, Dept Rheumatol & Clin Immunol, Charite Univ Med Berlin, Berlin, Germany
Zhou, Yijie
Othman, Ahmed A.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie, N Chicago, IL USA
Free Univ, Dept Rheumatol & Clin Immunol, Charite Univ Med Berlin, Berlin, Germany
Othman, Ahmed A.
Pangan, Aileen L.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, N Chicago, IL USA
Free Univ, Dept Rheumatol & Clin Immunol, Charite Univ Med Berlin, Berlin, Germany
Pangan, Aileen L.
Camp, Heidi S.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie, N Chicago, IL USA
Free Univ, Dept Rheumatol & Clin Immunol, Charite Univ Med Berlin, Berlin, Germany
Camp, Heidi S.
ARTHRITIS & RHEUMATOLOGY,
2017,
69
[24]
Discovery of the JAK1 selective kinase inhibitor AZD4205
Kettle, Jason G.
论文数:
0
引用数:
0
h-index:
0
Kettle, Jason G.
Su, Qibin
论文数:
0
引用数:
0
h-index:
0
Su, Qibin
Grimster, Neil
论文数:
0
引用数:
0
h-index:
0
Grimster, Neil
Kawatkar, Sameer
论文数:
0
引用数:
0
h-index:
0
Kawatkar, Sameer
Throner, Scott
论文数:
0
引用数:
0
h-index:
0
Throner, Scott
Woessner, Richard
论文数:
0
引用数:
0
h-index:
0
Woessner, Richard
Chen, Huawei
论文数:
0
引用数:
0
h-index:
0
Chen, Huawei
Bebernitz, Geraldine
论文数:
0
引用数:
0
h-index:
0
Bebernitz, Geraldine
Bell, Kristen
论文数:
0
引用数:
0
h-index:
0
Bell, Kristen
Anderson, Erica
论文数:
0
引用数:
0
h-index:
0
Anderson, Erica
Ruston, Linette
论文数:
0
引用数:
0
h-index:
0
Ruston, Linette
Winter-Holt, Jon
论文数:
0
引用数:
0
h-index:
0
Winter-Holt, Jon
Lyne, Paul
论文数:
0
引用数:
0
h-index:
0
Lyne, Paul
Vasbinder, Melissa
论文数:
0
引用数:
0
h-index:
0
Vasbinder, Melissa
Chuaqui, Claudio
论文数:
0
引用数:
0
h-index:
0
Chuaqui, Claudio
CANCER RESEARCH,
2017,
77
[25]
Discovery of the JAK1 selective kinase inhibitor AZD4205
Su, Qibin
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Su, Qibin
Kettle, Jason
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Kettle, Jason
Grimster, Neil
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Grimster, Neil
Vasbinder, Melissa
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Vasbinder, Melissa
Kawatkar, Sameer
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Kawatkar, Sameer
Throner, Scott
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Throner, Scott
Woessner, Rich
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Woessner, Rich
Chen, Huawei
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Chen, Huawei
Chuaqui, Claudio
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Chuaqui, Claudio
Bebernitz, Geraldine
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Bebernitz, Geraldine
Bell, Kristen
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Bell, Kristen
Anderson, Erica Anderson
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Anderson, Erica Anderson
Ruston, Linette
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Ruston, Linette
Winter-Holt, Jon
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Winter-Holt, Jon
Yang, Wenzhan
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Yang, Wenzhan
Lyne, Paul
论文数:
0
引用数:
0
h-index:
0
机构:
AstraZeneca, Waltham, MA USA
AstraZeneca, Waltham, MA USA
Lyne, Paul
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY,
2017,
254
[26]
A PHASE 3 RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF UPADACITINIB (ABT-494), A SELECTIVE JAK-1 INHIBITOR, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
Burmester, G.
论文数:
0
引用数:
0
h-index:
0
机构:
Charite, Berlin, Germany
Charite, Berlin, Germany
Burmester, G.
Kremer, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Albany Med Coll, Albany, NY 12208 USA
Charite, Berlin, Germany
Kremer, J.
论文数:
引用数:
h-index:
机构:
van den Bosch, F.
Li, Y.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, N Chicago, IL USA
Charite, Berlin, Germany
Li, Y.
Zhou, Y.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, N Chicago, IL USA
Charite, Berlin, Germany
Zhou, Y.
Othman, A.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, N Chicago, IL USA
Charite, Berlin, Germany
Othman, A.
Pangan, A.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, N Chicago, IL USA
Charite, Berlin, Germany
Pangan, A.
Camp, H.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, N Chicago, IL USA
Charite, Berlin, Germany
Camp, H.
ANNALS OF THE RHEUMATIC DISEASES,
2018,
77
: 68
-
69
[27]
PRECLINICAL CHARACTERIZATION OF CJ-15314, A HIGHLY SELECTIVE JAK1 INHIBITOR, FOR THE TREATMENT OF AUTOIMMUNE DISEASES
Ki, S. Y.
论文数:
0
引用数:
0
h-index:
0
机构:
CJ Healthcare, R&D Ctr, Seoul, South Korea
CJ Healthcare, R&D Ctr, Seoul, South Korea
Ki, S. Y.
Shin, H.
论文数:
0
引用数:
0
h-index:
0
机构:
CJ Healthcare, R&D Ctr, Seoul, South Korea
CJ Healthcare, R&D Ctr, Seoul, South Korea
Shin, H.
Lee, Y.
论文数:
0
引用数:
0
h-index:
0
机构:
CJ Healthcare, R&D Ctr, Seoul, South Korea
CJ Healthcare, R&D Ctr, Seoul, South Korea
Lee, Y.
Bak, H. R.
论文数:
0
引用数:
0
h-index:
0
机构:
CJ Healthcare, R&D Ctr, Seoul, South Korea
CJ Healthcare, R&D Ctr, Seoul, South Korea
Bak, H. R.
Yu, H.
论文数:
0
引用数:
0
h-index:
0
机构:
CJ Healthcare, R&D Ctr, Seoul, South Korea
CJ Healthcare, R&D Ctr, Seoul, South Korea
Yu, H.
Kim, S. C.
论文数:
0
引用数:
0
h-index:
0
机构:
CJ Healthcare, R&D Ctr, Seoul, South Korea
CJ Healthcare, R&D Ctr, Seoul, South Korea
Kim, S. C.
Lee, J.
论文数:
0
引用数:
0
h-index:
0
机构:
CJ Healthcare, R&D Ctr, Seoul, South Korea
CJ Healthcare, R&D Ctr, Seoul, South Korea
Lee, J.
Kim, D.
论文数:
0
引用数:
0
h-index:
0
机构:
CJ Healthcare, R&D Ctr, Seoul, South Korea
CJ Healthcare, R&D Ctr, Seoul, South Korea
Kim, D.
Ko, D. H.
论文数:
0
引用数:
0
h-index:
0
机构:
CJ Healthcare, R&D Ctr, Seoul, South Korea
CJ Healthcare, R&D Ctr, Seoul, South Korea
Ko, D. H.
Kim, D.
论文数:
0
引用数:
0
h-index:
0
机构:
CJ Healthcare, R&D Ctr, Seoul, South Korea
CJ Healthcare, R&D Ctr, Seoul, South Korea
Kim, D.
ANNALS OF THE RHEUMATIC DISEASES,
2020,
79
: 1343
-
1343
[28]
Ruxolitinib, a selective JAK1 and JAK2 inhibitor for the treatment of myeloproliferative neoplasms and psoriasis
Mesa, Ruben A.
论文数:
0
引用数:
0
h-index:
0
机构:
Mayo Clin, Div Hematol & Oncol, Scottsdale, AZ 85259 USA
Mayo Clin, Div Hematol & Oncol, Scottsdale, AZ 85259 USA
Mesa, Ruben A.
IDRUGS,
2010,
13
(06)
: 394
-
403
[29]
A PHASE-3 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF UPADACITINIB (ABT-494), A SELECTIVE JAK-1 INHIBITOR, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
Burmester, Gerd R.
论文数:
0
引用数:
0
h-index:
0
机构:
Charite, Berlin, Germany
Charite, Berlin, Germany
Burmester, Gerd R.
Kremer, Joel M.
论文数:
0
引用数:
0
h-index:
0
机构:
Albany Med Coll, Albany, NY 12208 USA
Charite, Berlin, Germany
Kremer, Joel M.
论文数:
引用数:
h-index:
机构:
van den Bosch, Filip
Li, Yihan
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, N Chicago, IL USA
Charite, Berlin, Germany
Li, Yihan
Zhou, Yijie
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, N Chicago, IL USA
Charite, Berlin, Germany
Zhou, Yijie
Othman, Ahmed A.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, N Chicago, IL USA
Charite, Berlin, Germany
Othman, Ahmed A.
Pangan, Aileen L.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, N Chicago, IL USA
Charite, Berlin, Germany
Pangan, Aileen L.
Camp, Heidi S.
论文数:
0
引用数:
0
h-index:
0
机构:
AbbVie Inc, N Chicago, IL USA
Charite, Berlin, Germany
Camp, Heidi S.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY,
2018,
24
: S88
-
S88
[30]
IN-115314, THE BEST SELECTIVE JAK1 INHIBITOR FOR THE TREATMENT OF ATOPIC DERMATITIS
Choi, Jong-Ryoul
论文数:
0
引用数:
0
h-index:
0
机构:
HK Inno N Corp, Res Inst, Seoul, South Korea
HK Inno N Corp, Res Inst, Seoul, South Korea
Choi, Jong-Ryoul
Byeon, Yeji
论文数:
0
引用数:
0
h-index:
0
机构:
HK Inno N Corp, Res Inst, Seoul, South Korea
HK Inno N Corp, Res Inst, Seoul, South Korea
Byeon, Yeji
Yoon, Daseul
论文数:
0
引用数:
0
h-index:
0
机构:
HK Inno N Corp, Res Inst, Seoul, South Korea
HK Inno N Corp, Res Inst, Seoul, South Korea
Yoon, Daseul
Shin, Hyunwoo
论文数:
0
引用数:
0
h-index:
0
机构:
HK Inno N Corp, Res Inst, Seoul, South Korea
HK Inno N Corp, Res Inst, Seoul, South Korea
Shin, Hyunwoo
Lee, Juhyun
论文数:
0
引用数:
0
h-index:
0
机构:
HK Inno N Corp, Res Inst, Seoul, South Korea
HK Inno N Corp, Res Inst, Seoul, South Korea
Lee, Juhyun
Jung, Seunghee
论文数:
0
引用数:
0
h-index:
0
机构:
HK Inno N Corp, Res Inst, Seoul, South Korea
HK Inno N Corp, Res Inst, Seoul, South Korea
Jung, Seunghee
Ko, Donghyun
论文数:
0
引用数:
0
h-index:
0
机构:
HK Inno N Corp, Res Inst, Seoul, South Korea
HK Inno N Corp, Res Inst, Seoul, South Korea
Ko, Donghyun
Kim, Dongkyu
论文数:
0
引用数:
0
h-index:
0
机构:
HK Inno N Corp, Res Inst, Seoul, South Korea
HK Inno N Corp, Res Inst, Seoul, South Korea
Kim, Dongkyu
ACTA DERMATO-VENEREOLOGICA,
2021,
101
: 35
-
36
←
1
2
3
4
5
→